Duchenne muscular dystrophy

被引:207
|
作者
Yiu, Eppie M. [1 ,2 ,3 ,4 ]
Kornberg, Andrew J. [1 ,3 ,4 ]
机构
[1] Royal Childrens Hosp Melbourne, Dept Neurol, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Bruce Lefroy Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Neurosci Res, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
corticosteroid; Duchenne; gene therapy; muscular dystrophy; non-invasive ventilation; positive pressure; HOME NOCTURNAL VENTILATION; CORTICOSTEROID TREATMENT; BECKER; SCOLIOSIS; SURVIVAL; CARRIERS; ANESTHESIA; MANAGEMENT; DISORDERS; SPECTRUM;
D O I
10.1111/jpc.12868
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Duchenne muscular dystrophy, an X-linked disorder, has an incidence of one in 5000 boys and presents in early childhood with proximal muscle weakness. Untreated boys become wheelchair bound by the age of 12 years and die of cardiorespiratory complications in their late teens to early 20s. The use of corticosteroids, non-invasive respiratory support, and active surveillance and management of associated complications have improved ambulation, function, quality of life and life expectancy. The clinical features, investigations and management of Duchenne muscular dystrophy are reviewed, as well as the latest in some of the novel therapies.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 50 条
  • [31] Adults with Duchenne Muscular Dystrophy
    Eagle, Michelle
    Straub, Volker
    Bushby, Kate
    NEUROMUSCULAR DISORDERS, 2006, 16 : S120 - S120
  • [32] Challenges in Duchenne muscular dystrophy
    Davies, KE
    NEUROMUSCULAR DISORDERS, 1997, 7 (08) : 482 - 486
  • [33] Biomarkers in Duchenne Muscular Dystrophy
    Theo Lee-Gannon
    Xuan Jiang
    Tara C. Tassin
    Pradeep P. A. Mammen
    Current Heart Failure Reports, 2022, 19 : 52 - 62
  • [34] DUCHENNE MUSCULAR-DYSTROPHY
    SUGITA, H
    JAPANESE JOURNAL OF HUMAN GENETICS, 1987, 32 (02): : 119 - 121
  • [35] Electrocardiogram in Duchenne muscular dystrophy
    Velayutham, R.
    Anitha, R. M.
    Vellingiri, Sureshkumar
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2024,
  • [36] Golodirsen for Duchenne muscular dystrophy
    Anwar, S.
    Yokota, T.
    DRUGS OF TODAY, 2020, 56 (08) : 491 - 504
  • [37] Update on Duchenne muscular dystrophy
    Leiva-Cepas, F.
    Montano Martinez, A.
    Lopez-Lopez, I
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (07): : 472 - 481
  • [38] Duchenne muscular dystrophy and epilepsy
    Pane, M.
    Messina, S.
    Bruno, C.
    D'Amico, A.
    Villanova, M.
    Brancalion, B.
    Sivo, S.
    Bianco, F.
    Striano, P.
    Battaglia, D.
    Letiori, D.
    Vita, G. L.
    Bertini, E.
    Gualandi, F.
    Ricotti, V.
    Ferlini, A.
    Mercuri, E.
    NEUROMUSCULAR DISORDERS, 2013, 23 (04) : 313 - 315
  • [39] Duchenne muscular dystrophy - Reply
    Simonds, AK
    THORAX, 1999, 54 (06) : 564 - 564
  • [40] Casimersen for Duchenne muscular dystrophy
    Wilton-Clark, H.
    Yokota, T.
    DRUGS OF TODAY, 2021, 57 (12) : 707 - 717